Loading...

Efficacy and Safety of Nivolumab and Ipilimumab for Advanced or Metastatic Renal Cell Carcinoma: A Multicenter Retrospective Cohort Study

We conducted a multicenter, retrospective study to evaluate the efficacy and safety of combination nivolumab plus ipilimumab (NIVO+IPI) in 35 patients with advanced or metastatic renal cell carcinoma (mRCC). In this study, we focused on patients who received NIVO+IPI and were stratified into interme...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Curr Oncol
Main Authors: Iinuma, Koji, Kameyama, Koji, Kawada, Kei, Fujimoto, Shota, Takagi, Kimiaki, Nagai, Shingo, Ito, Hiroki, Ishida, Takashi, Kawase, Makoto, Kawase, Kota, Nakai, Chie, Kato, Daiki, Takai, Manabu, Nakane, Keita, Koie, Takuya
Format: Artigo
Sprog:Inglês
Udgivet: MDPI 2021
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8167798/
https://ncbi.nlm.nih.gov/pubmed/33916792
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/curroncol28020133
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!